- Home
- ARWR vs ATRC Comparison
ARWR vs ATRC Comparison
Compare ARWR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ATRC
- Stock Information
- Founded
- ARWR 2003
- ATRC 2000
- Country
- ARWR United States
- ATRC United States
- Employees
- ARWR N/A
- ATRC N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ATRC Medical/Dental Instruments
- Sector
- ARWR Health Care
- ATRC Health Care
- Exchange
- ARWR Nasdaq
- ATRC Nasdaq
- Market Cap
- ARWR 1.8B
- ATRC 1.5B
- IPO Year
- ARWR 1993
- ATRC 2005
- Fundamental
- Price
- ARWR $13.07
- ATRC $30.89
- Analyst Decision
- ARWR Buy
- ATRC Strong Buy
- Analyst Count
- ARWR 11
- ATRC 10
- Target Price
- ARWR $41.44
- ATRC $49.60
- AVG Volume (30 Days)
- ARWR 1.7M
- ATRC 716.7K
- Earning Date
- ARWR 05-12-2025
- ATRC 04-29-2025
- Dividend Yield
- ARWR N/A
- ATRC N/A
- EPS Growth
- ARWR N/A
- ATRC N/A
- EPS
- ARWR N/A
- ATRC N/A
- Revenue
- ARWR $2,500,000.00
- ATRC $480,076,000.00
- Revenue This Year
- ARWR $4,380.43
- ATRC $14.60
- Revenue Next Year
- ARWR $64.24
- ATRC $12.58
- P/E Ratio
- ARWR N/A
- ATRC N/A
- Revenue Growth
- ARWR N/A
- ATRC 15.79
- 52 Week Low
- ARWR $9.57
- ATRC $18.94
- 52 Week High
- ARWR $30.41
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- ARWR 53.31
- ATRC 45.77
- Support Level
- ARWR $12.44
- ATRC $28.52
- Resistance Level
- ARWR $14.97
- ATRC $31.82
- Average True Range (ATR)
- ARWR 0.71
- ATRC 1.53
- MACD
- ARWR 0.16
- ATRC -0.02
- Stochastic Oscillator
- ARWR 61.36
- ATRC 36.25
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.